Table 1.
Baseline characteristics after matching.
| Surgical group | GLP-1A group | Standardized mean difference | |
|---|---|---|---|
| n | 2161 | 2161 | |
| Age | 51.1 ± 9.29 | 51.5 ± 8.92 | 0.048 |
| BMI | 40.8 ± 5.49 | n/a | |
| Sex | 0.009 | ||
| Men | 760 (35.2%) | 769 (35.6%) | |
| Women | 1401 (64.8%) | 1392 (64.4%) | |
| Education | 0.016 | ||
| Primary | 393 (18.2%) | 378 (17.5%) | |
| Secondary | 1198 (55.4%) | 1205 (55.8%) | |
| Higher | 570 (26.4%) | 578 (26.7%) | |
| Disposable income | 0.045 | ||
| Q1 | 545 (25.2%) | 589 (27.3%) | |
| Q2 | 598 (27.7%) | 619 (28.6%) | |
| Q3 | 569 (26.3%) | 501 (23.2%) | |
| Q4 | 449 (20.8%) | 452 (20.9%) | |
| Cardiovascular comorbidity | 280 (13.0%) | 285 (13.2%) | 0.007 |
| Dyslipidaemia | 1258 (58.2%) | 1275 (59.0%) | 0.016 |
| COPD | 103 (4.8%) | 108 (5.0%) | 0.010 |
| Surgical method | |||
| Sleeve gastrectomy | 413 (19.1%) | n/a | |
| Gastric bypass | 1748 (80.9%) | n/a | |
| Number of diabetes drugs | 2.5 ± 0.89 | 2.6 ± 0.87 | 0.098 |
| Insulin | 968 (44.2%) | 925 (42.8%) | 0.040 |
| Diabetes duration | 6.0 ± 4.15 | 6.0 ± 4.51 | 0.007 |
n number, BMI body mass index, Qi quartile, COPD chronic obstructive pulmonary disorder, GLP-1A Glucagon-like Peptide-1 receptor agonist.